A Milestone Meeting For US FDA: Vaccine Reviews After COVID

 
• By Michael McCaughan
  
Milestone
THE ROAD AHEAD FOR VRBPAC WILL INCLUDE NEW FACES AT OVRR AND LESS FOCUS ON COVID VACCINES. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers